RecruitingNCT06844851

Evaluation of Genetic-molecular Causes of Out-of-Hospital Cardiac Arrest: From Patients to Families


Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Enrollment

1,725 participants

Start Date

Sep 9, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The aims are to define the exact prevalence of hereditary heart diseases in out-of-hospital cardiac arrest (OHCA) patients taking also into account gender, patient and OHCA characteristics, provincial settings and environmental pollution; to stratify the individualized arrhythmic risk of proband's family members to prevent further sudden cardiac deaths; to refine the classification of the variants of uncertain significance (VUS) on genes which can have the capability to drive to molecular alterations leading to arrhythmogenic hereditary heart diseases. A blood sample will be obtained during resuscitation from all the patients aged ≤50 years suffering an OHCA in Lombardy Region and then analysed for genetic variants possibly causative of cardiac diseases. Genetic data will be merged with patient, OHCA and post-resuscitation data thanks to the connection with LombardiaCARe, whilst pollution data will be retrieved from ARPA Lombardia for free. A genetic counselling and clinical-instrumental evaluation of the proband's first-degree family members will be performed if a pathogenic/likely pathogenic variant or a VUS will be disclosed during the genetic analysis.


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Inclusion Criteria1

  • All the patients suffering from OHCA of medical etiology in Lombardy Region ≤50 years, for whom resuscitation manoeuvres was started by EMS (AREU)

Exclusion Criteria2

  • Patients under 18 years old
  • Patients with a non-medical cause of the cardiac arrest

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Fondazione IRCCS Policlinico San Matteo di Pavia

Pavia, Pavia, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06844851


Related Trials